JP2023507561A5 - - Google Patents
Info
- Publication number
- JP2023507561A5 JP2023507561A5 JP2022535058A JP2022535058A JP2023507561A5 JP 2023507561 A5 JP2023507561 A5 JP 2023507561A5 JP 2022535058 A JP2022535058 A JP 2022535058A JP 2022535058 A JP2022535058 A JP 2022535058A JP 2023507561 A5 JP2023507561 A5 JP 2023507561A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- storage
- amino acid
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025175127A JP2026016480A (ja) | 2019-12-10 | 2025-10-17 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962946207P | 2019-12-10 | 2019-12-10 | |
| US62/946,207 | 2019-12-10 | ||
| PCT/US2020/064025 WO2021119135A1 (en) | 2019-12-10 | 2020-12-09 | Stabilized formulations containing anti-cd20 x anti-cd3 bispecific antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175127A Division JP2026016480A (ja) | 2019-12-10 | 2025-10-17 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023507561A JP2023507561A (ja) | 2023-02-24 |
| JP2023507561A5 true JP2023507561A5 (https=) | 2023-12-18 |
| JP7813703B2 JP7813703B2 (ja) | 2026-02-13 |
Family
ID=74141846
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535058A Active JP7813703B2 (ja) | 2019-12-10 | 2020-12-09 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
| JP2025175127A Pending JP2026016480A (ja) | 2019-12-10 | 2025-10-17 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175127A Pending JP2026016480A (ja) | 2019-12-10 | 2025-10-17 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20210206870A1 (https=) |
| EP (1) | EP4072585A1 (https=) |
| JP (2) | JP7813703B2 (https=) |
| KR (1) | KR20220113417A (https=) |
| CN (1) | CN115003331A (https=) |
| AU (1) | AU2020402030A1 (https=) |
| BR (1) | BR112022011150A2 (https=) |
| CA (1) | CA3161059A1 (https=) |
| CL (3) | CL2022001495A1 (https=) |
| CO (1) | CO2022008684A2 (https=) |
| IL (1) | IL293372A (https=) |
| MY (1) | MY210570A (https=) |
| PH (1) | PH12022551275A1 (https=) |
| TW (1) | TW202135860A (https=) |
| WO (1) | WO2021119135A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202400228A (zh) | 2022-02-25 | 2024-01-01 | 美商再生元醫藥公司 | 減輕細胞激素釋放症候群的給藥方案 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0747045B2 (ja) | 1986-10-15 | 1995-05-24 | 株式会社大協精工 | 積層した注射器用滑栓 |
| JP3100727B2 (ja) | 1992-01-23 | 2000-10-23 | 株式会社大協精工 | 変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品 |
| JP3172057B2 (ja) | 1995-04-05 | 2001-06-04 | 株式会社大協精工 | ラミネートゴム栓 |
| JP3512349B2 (ja) | 1999-01-29 | 2004-03-29 | 株式会社大協精工 | 柱状ゴム要素の成形型 |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| JP2002209975A (ja) | 2001-01-19 | 2002-07-30 | Daikyo Seiko Ltd | 医薬バイアル用ラミネートゴム栓 |
| JP2007526220A (ja) * | 2003-06-05 | 2007-09-13 | ジェネンテック・インコーポレーテッド | Ｂ細胞疾患の併用療法 |
| WO2009070642A1 (en) * | 2007-11-28 | 2009-06-04 | Medimmune, Llc | Protein formulation |
| JP2012041317A (ja) * | 2010-08-23 | 2012-03-01 | Panasonic Corp | フェロセン修飾抗体 |
| PT2691112T (pt) * | 2011-03-31 | 2018-07-10 | Merck Sharp & Dohme | Formulações estáveis de anticorpos para o recetor pd-1 humano de morte programada e tratamentos relacionados |
| JOP20200236A1 (ar) | 2012-09-21 | 2017-06-16 | Regeneron Pharma | الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها |
| IL263466B2 (en) * | 2013-12-17 | 2023-10-01 | Genentech Inc | Anti-CD3 antibodies and methods of using them |
| KR102614189B1 (ko) * | 2014-11-17 | 2023-12-18 | 리제너론 파아마슈티컬스, 인크. | Cd3xcd20 이특이적 항체를 이용한 종양의 치료 방법 |
| AU2016378573A1 (en) * | 2015-12-22 | 2018-07-19 | Regeneron Pharmaceuticals, Inc. | Bispecific anti-CD20/anti-CD3 antibodies to treat acute lymphoblastic leukemia |
| TWI865430B (zh) | 2017-07-24 | 2024-12-11 | 美商再生元醫藥公司 | 穩定化之抗體組合物及其製法 |
| KR20200037863A (ko) * | 2017-08-25 | 2020-04-09 | 오메로스 코포레이션 | 고도로 농축된 저점도 masp-2 억제 항체 제제, 키트, 및 비정형 용혈성 증후군을 앓고 있는 대상체의 치료 방법 |
| AU2022214319A1 (en) * | 2021-01-28 | 2023-08-03 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for treating cytokine release syndrome |
-
2020
- 2020-12-08 TW TW109143208A patent/TW202135860A/zh unknown
- 2020-12-09 KR KR1020227021715A patent/KR20220113417A/ko active Pending
- 2020-12-09 PH PH1/2022/551275A patent/PH12022551275A1/en unknown
- 2020-12-09 CN CN202080092885.6A patent/CN115003331A/zh active Pending
- 2020-12-09 AU AU2020402030A patent/AU2020402030A1/en active Pending
- 2020-12-09 JP JP2022535058A patent/JP7813703B2/ja active Active
- 2020-12-09 BR BR112022011150A patent/BR112022011150A2/pt unknown
- 2020-12-09 IL IL293372A patent/IL293372A/en unknown
- 2020-12-09 US US17/116,699 patent/US20210206870A1/en not_active Abandoned
- 2020-12-09 WO PCT/US2020/064025 patent/WO2021119135A1/en not_active Ceased
- 2020-12-09 CA CA3161059A patent/CA3161059A1/en active Pending
- 2020-12-09 EP EP20838711.8A patent/EP4072585A1/en active Pending
- 2020-12-09 MY MYPI2022003031A patent/MY210570A/en unknown
-
2022
- 2022-06-07 CL CL2022001495A patent/CL2022001495A1/es unknown
- 2022-06-22 CO CONC2022/0008684A patent/CO2022008684A2/es unknown
-
2024
- 2024-05-22 CL CL2024001536A patent/CL2024001536A1/es unknown
- 2024-11-11 CL CL2024003444A patent/CL2024003444A1/es unknown
-
2025
- 2025-04-07 US US19/171,676 patent/US20250236677A1/en active Pending
- 2025-10-17 JP JP2025175127A patent/JP2026016480A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7440464B2 (ja) | 抗アクチビンａ抗体及びその使用 | |
| AU2020201219B2 (en) | Methods of treating or preventing cholesterol related disorders | |
| RU2363706C2 (ru) | Антитела к рецептору инсулиноподобного фактора роста i и их применение | |
| RU2497544C2 (ru) | Жидкая композиция, содержащая антитело высокой концентрации | |
| AU2021202839A1 (en) | Human antibodies to ebola virus glycoprotein | |
| FI3606504T3 (fi) | Stabiili vasta-aineformulaatio | |
| RU2017107847A (ru) | Стабильный состав на основе антитела к il-4r-альфа | |
| JP2021515566A5 (https=) | ||
| JP2023011710A (ja) | Ｓ．ａｕｒｅｕｓ溶血素ａ毒素に対するヒト抗体 | |
| JP2009507838A (ja) | 抗ｃｄ３抗体製剤 | |
| JP2020518598A5 (https=) | ||
| JP2023545183A5 (https=) | ||
| JP2023507561A5 (https=) | ||
| JP2025502061A5 (https=) | ||
| WO2010132872A1 (en) | Combination therapies and methods using anti-cd3 modulating agents and anti-tnf antagonists | |
| JP2024513835A5 (https=) | ||
| CN114685653B (zh) | 抗新冠病毒受体结合区域表位中和抗体及其应用 | |
| JP2021500865A (ja) | スタフィロコッカス（Ｓｔａｐｈｓｙｌｏｃｏｃｃｕｓ）標的抗原および補体成分に結合する二重特異性抗原結合分子ならびにその使用 | |
| RU2745814C1 (ru) | Водная фармацевтическая композиция левилимаба и ее применение | |
| KR20240100493A (ko) | 항-cd22 항체의 수성 제제 및 이의 용도 | |
| AU2022246842A1 (en) | Multispecific binding moieties comprising novel pd-1 binding domains | |
| JP2024502670A5 (https=) | ||
| RU2024122332A (ru) | СПОСОБЫ ЛЕЧЕНИЯ РЕЦИДИВИРУЮЩЕГО РАКА ЯИЧНИКА С ПОМОЩЬЮ БИСПЕЦИФИЧНЫХ АНТИТЕЛ К MUC16 x CD3 ОТДЕЛЬНО ИЛИ В КОМБИНАЦИИ С АНТИТЕЛАМИ К PD-1 | |
| US20240392021A1 (en) | Pharmaceutical formulations containing anti-ox40l antibodies | |
| RU2026105218A (ru) | Способы лечения светлоклеточного рака почек с помощью биспецифических антител к psma/cd28 |